Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alexion
Alexion
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
Fierce Pharma
Thu, 09/14/23 - 11:00 pm
Alexion
AstraZeneca
Soliris
investors
legal
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
AstraZeneca
M&A
Alexion
LogicBio Therapeutics
genomic medicine
AstraZeneca's Alexion bet continues to pay off as danicopan improves hemoglobin levels in phase 3
Fierce Biotech
Mon, 09/19/22 - 09:25 am
AstraZeneca
Alexion
danicopan
paroxysmal nocturnal hemoglobinuria
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
Fri, 06/24/22 - 10:26 am
AstraZeneca
Wilson disease
Alexion
ALXN1840
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
Fierce Biotech
Mon, 04/18/22 - 10:48 am
AstraZeneca
Alexion
Arvinas
Connecticut
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Roche
Chugai
AstraZeneca
Alexion
patents
Ultomiris
Soliris
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Mon, 01/10/22 - 11:43 am
Alexion
AstraZeneca
Neurimmune
NI006
ATTR-CM
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
AstraZeneca
Alexion
Sobi
M&A
AstraZeneca’s Alexion concludes Caelum acquisition for $500m
Pharmaceutical Business Review
Thu, 10/7/21 - 11:22 am
AstraZeneca
Alexion
Caelum Biosciences
M&A
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin
Fierce Pharma
Tue, 09/21/21 - 10:50 pm
AstraZeneca
Alexion
Ireland
drug manufacturing
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
Thu, 08/26/21 - 11:09 am
AstraZeneca
Alexion
ALXN1840
Wilson disease
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
Fierce Pharma
Sun, 07/25/21 - 11:44 am
AstraZeneca
Soliris
Alexion
drug pricing
myasthenia gravis
AstraZeneca heralds new chapter as Alexion acquisition completed
Biopharma Reporter
Wed, 07/21/21 - 08:46 pm
AstraZeneca
Alexion
M&A
Biopharma throws grease on the deal wheels
EP Vantage
Wed, 07/21/21 - 10:52 am
M&A
Alexion
Achillion
Eli Lilly
Prevail Therapeutics
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Fierce Pharma
Wed, 07/21/21 - 12:01 am
AstraZeneca
Alexion
Ultomiris
Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?
Motley Fool
Mon, 07/19/21 - 10:52 am
Moderna Therapeutics
Alexion
S&P 500
vaccines
COVID-19
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Endpoints
Fri, 07/16/21 - 10:40 am
Alexion
AstraZeneca
M&A
clinical trials
Ultomiris
myasthenia gravis
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »